|
531 |
Role of Tissue Doppler Imaging for Detection of Diastolic Dysfunction in the Elderly Enthalten in High blood pressure & cardiovascular prevention Bd. 18, 4.11.2012, Nr. 4, date:12.2011: 187-193
|
|
|
532 |
Rosuvastatin-Associated Adverse Effects and Drug-Drug Interactions in the Clinical Setting of Dyslipidemia Enthalten in American journal of cardiovascular drugs Bd. 10, 17.8.2012, Nr. 1, date:2.2010: 11-28
|
|
|
533 |
Rotavirus Infections and Vaccines Enthalten in Pediatric drugs Bd. 12, 31.8.2012, Nr. 4, date:8.2010: 235-256
|
|
|
534 |
Routine Plasma Anti-Xa Monitoring is Required for Low-Molecular-Weight Heparins Enthalten in Clinical pharmacokinetics Bd. 49, 18.12.2012, Nr. 9, date:9.2010: 567-571
|
|
|
535 |
Ruxolitinib Enthalten in Drugs Bd. 72, 25.12.2012, Nr. 16, date:12.2012: 2117-2127
|
|
|
536 |
RVX 208 Enthalten in Drugs in R & D Bd. 11, 27.11.2012, Nr. 2, date:6.2011: 207-213
|
|
|
537 |
Safety and Efficacy of Buprenorphine/Naloxone in Opioid-Dependent Patients Enthalten in Clinical drug investigation Bd. 30, 17.9.2012, Nr. 1, date:4.2010: 21-26
|
|
|
538 |
Safety and Efficacy of Topical Diclofenac Sodium Gel for Knee Osteoarthritis in Elderly and Younger Patients Enthalten in Drugs & aging Bd. 28, 31.8.2012, Nr. 1, date:1.2011: 27-40
|
|
|
539 |
Safety and Tolerability of a New Formulation of Pancrelipase Delayed-Release Capsules (CREON®) in Children Under Seven Years of Age with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis Enthalten in Clinical drug investigation Bd. 30, 28.8.2012, Nr. 6, date:6.2010: 351-364
|
|
|
540 |
Safety and Tolerability of an SQ-Standardized GRAss ALlergy Immunotherapy Tablet (GRAZAX®) in a Real-Life Setting for Three Consecutive Seasons — The GRAAL Trial Enthalten in Clinical drug investigation Bd. 32, 13.12.2012, Nr. 7, date:7.2012: 451-463
|
|